Literature DB >> 19823827

[Identification of genes over-expressed in myxoid/round cell liposarcoma. DNA microarray analysis and immunohistochemical correlation].

C Lanckohr1, A Kasprzynski, L Klein-Hitpass, H-H Homann, M Lehnhardt, O Müller, C Kuhnen, P Herter.   

Abstract

Myxoid/round cell liposarcoma are characterized by typical chromosomal translocations. This genetic alteration might result in specific gene-expression profiles in this tumor entity. To identify over-expressed genes in myxoid/round cell liposarcoma DNA microarray analysis was performed on four tumors and four samples of adult fat tissue. Genes ret, cdk4, cyclin D2 and c-myc showed over-expression by means of microarray analysis and Northern blotting. Immunohistochemistry demonstrated cytoplasmic localization of associated proteins in 36 different tumors. The localization of ret was seen in endothelial cells of plexiform vasculature in addition to its accumulation in tumor cells (25% of cases). The results show an over-expression of cdk4, cyclin D2, c-myc and ret on both the transcriptional and protein level in myxoid/round cell liposarcoma. For cyclin D2 and ret this finding has not been reported in this tumor type. The increase of ret on transcriptional level might be explained by its expression in endothelium in intratumoral plexiform blood vessels. For the molecular pathogenesis of myxoid/round cell liposarcoma our findings imply the involvement of these four genes in the deregulation of the cell cycle, especially as cdk4 and cyclin D2 are target genes of c-myc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19823827     DOI: 10.1007/s00292-009-1234-0

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  30 in total

1.  Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

Authors:  C Bouchard; O Dittrich; A Kiermaier; K Dohmann; A Menkel; M Eilers; B Lüscher
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

2.  Analysis of human telomerase reverse transcriptase mRNA (hTERT) expression in myxoid liposarcomas using LightCycler real-time quantitative reverse transcriptase-polymerase chain reaction.

Authors:  R Schneider-Stock; T Emrich; B Peters; V Jaeger; A Roessner
Journal:  Electrophoresis       Date:  2001-04       Impact factor: 3.535

Review 3.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma.

Authors:  Avery A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  2004-11

4.  Identification of CDK4 as a target of c-MYC.

Authors:  H Hermeking; C Rago; M Schuhmacher; Q Li; J F Barrett; A J Obaya; B C O'Connell; M K Mateyak; W Tam; F Kohlhuber; C V Dang; J M Sedivy; D Eick; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

5.  High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas.

Authors:  R Schneider-Stock; V Jaeger; J Rys; J T Epplen; A Roessner
Journal:  Int J Cancer       Date:  2000-01-20       Impact factor: 7.396

6.  Molecular characterisation of soft tissue tumours: a gene expression study.

Authors:  Torsten O Nielsen; Rob B West; Sabine C Linn; Orly Alter; Margaret A Knowling; John X O'Connell; Shirley Zhu; Mike Fero; Gavin Sherlock; Jonathan R Pollack; Patrick O Brown; David Botstein; Matt van de Rijn
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

7.  [liposarcoma. Aspects of pathomorphology--an analysis of 209 tumos].

Authors:  C Kuhnen; M Lehnhardt; H U Steinau; K-M Müller
Journal:  Chirurg       Date:  2004-12       Impact factor: 0.955

Review 8.  Pathology and genetics of adipocytic tumors.

Authors:  M Hameed
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

Review 9.  RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Expert Rev Anticancer Ther       Date:  2008-04       Impact factor: 4.512

10.  Different mRNA expression profile during tumor progression in a well-differentiated liposarcoma--A microdissection approach.

Authors:  Regine Schneider-Stock; F Gerresheim; I Kolin-Gerresheim; F Meyer; V Jäger; J T Epplen; A Roessner; C Boltze
Journal:  Pathol Res Pract       Date:  2003       Impact factor: 3.250

View more
  2 in total

Review 1.  Advances in the targeted therapy of liposarcoma.

Authors:  Zhonghai Guan; Xiongfei Yu; Haohao Wang; Haiyong Wang; Jing Zhang; Guangliang Li; Jiang Cao; Lisong Teng
Journal:  Onco Targets Ther       Date:  2015-01-05       Impact factor: 4.147

2.  HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.

Authors:  Setareh Safavi; Sofia Järnum; Christoffer Vannas; Sameer Udhane; Emma Jonasson; Tajana Tesan Tomic; Pernilla Grundevik; Henrik Fagman; Magnus Hansson; Zeynep Kalender; Alexandra Jauhiainen; Soheila Dolatabadi; Eva Wessel Stratford; Ola Myklebost; Mikael Eriksson; Göran Stenman; Regine Schneider-Stock; Anders Ståhlberg; Pierre Åman
Journal:  Oncotarget       Date:  2016-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.